Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
121,543,157
-
Total 13F shares
-
13,007,586
-
Share change
-
-255,931
-
Total reported value
-
$31,748,000
-
Price per share
-
$2.42
-
Number of holders
-
17
-
Value change
-
-$644,939
-
Number of buys
-
7
-
Number of sells
-
2
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) as of Q4 2020
As of 31 Dec 2020,
Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,007,586 shares.
The largest 10 holders included
NEA Management Company, LLC, TPG Group Holdings (SBS) Advisors, Inc., Omega Fund Management, LLC, FMR LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., and CANADA PENSION PLAN INVESTMENT BOARD.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.